% | $
Quotes you view appear here for quick access.

Given ImAŞing Ltd. Şti. Message Board

  • bim555bam bim555bam Jan 25, 2005 10:36 AM Flag


    The approval from one of the urope cauntries [italy frrance or germany]sooner than you think

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • poco poco

    • are linked more often in Europe and Japan than they are in the US. In fact, the approval often includes what procedures will be reimbursed and at what rate.

      If the approval

      1) goes beyond small bleeding indications and

      2) is for initial Crohn's diagnosis and

      3) is in France or Germany (not Italy)

      that would be very good news.

      But that's a lot of ifs and boolean "and" filters.


    • Where did you see it?

      • 2 Replies to assaf01
      • Maybe from " Given Imaging's headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel; it has direct sales and marketing operations in the United States, Germany and France, and local offices in Tokyo, Madrid and Sydney. For more information, visit

        My guess is that Germany will come next in line,after all Austria & Switzerland initiated reimbursement more than 1 year ago

      • Italy is quite old news;
        Given Imaging Announces Reimbursement Coverage for PillCam� SB Endoscopy in Piemonte Region of Italy

        - 4.3 Million Italians Now Have Reimbursed Access for Expanded Indications -

        YOQNEAM, Israel, September 24, 2004 -- Given Imaging (Nasdaq: GIVN) today announced that the regional government of Italy�s Piemonte region has approved reimbursement for PillCam� endoscopy for the region�s 4.3 million individuals. Reimbursement has been approved as an outpatient procedure for broad indications including, Crohn�s disease, celiac disease, lymphoma, polyposis and occult bleeding. This decision went into effect September 9, 2004.

        �Based on the growing body of clinical and outcomes data, PillCam� endoscopy is the most effective method for detecting small bowel disorders. The availability of public reimbursement means that more individuals in Piemonte who are suffering from symptoms of small bowel disorders will now have access to this technology,� said Marco Pennazio, MD Division of Gastroenterology, S Giovanni Antica Sede Hospital, Turin.